Unedited news and product information from vendors.
Global Pharma Selects Semantelli's Compliance Ready Social Listening Platform to Manage Corporate Reputation
Jan 04, 2012 (05:01 PM EST)
Native Adverse Events handling was a key decision factor.
BRIDGEWATER, N.J., Jan. 4, 2012 /PRNewswire-iReach/ -- Semantelli Corporation announced today that a leading biopharmaceutical company has chosen Semantelli's CoProtect® to manage its online and social media reputation. CoProtect® is the life sciences industries' first compliance ready, actionable online reputation platform.
Semantelli's compliance ready, life sciences specific social listening solutions have helped top companies uncover previously unknown threats and opportunities emerging from web and social media.
"This is a clear indication that, our ability to natively identify and handle adverse events and off-label comments in social media is making our customers comfortable when it comes to social listening. Selection of Semantelli over horizontal social media monitoring and reputation tools validates that the needs of life sciences companies are different. Horizontal social media monitoring tools fail to address the compliance challenges life sciences companies face when it comes to monitoring social media." said Siva Nadarajah, CEO of Semantelli Corp.
In August of 2011, Semantelli launched AETracker to help pharmaceutical companies monitor and manage adverse events reported on company owned Facebook pages and other social media outlets. Since the launch, AETracker has been deployed by top 10 pharma and OTC companies to manage and protect brand sponsored social media outlets.
For more information visit: http://www.semantelli.com/pharma/coprotect
Semantelli is a privately-held company headquartered in Bridgewater, NJ.
For more information go to: http://www.semantelli.com/pharma/
Media Contact: Siva Nadarajah Semantelli Corp., 1-866-277-9057, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Semantelli Corp.